Tomasz Zieliński

Statistics

Publications

Citations

658

H-Index

Active since

1994

Affiliations

Institute of Nuclear Physics, Polish Academy of Sciences(Current)

Biogen (United States)

University of Łódź

Baylor University

Polish Academy of Sciences

Tomasz Zieliński is an author at Institute of Nuclear Physics, Polish Academy of Sciences specializing in life sciences, immunology, and relapsing-remitting multiple sclerosis treatment.

ORCID

Publications per year

1994–2023

Publications

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 185 citations

Life Sciences, Immunology, Neurology +11

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin

Beata Olas, Barbara Wachowicz, Joanna Saluk et al. · Thrombosis Research · 2002 · 99 citations

Medicine, Biochemistry, Pharmacology +14

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

David H. Miller, Robert J. Fox, J. Theodore Phillips et al. · Neurology · 2015 · 65 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Indenting soft samples (hydrogels and cells) with cantilevers possessing various shapes of probing tip

Joanna Zemła, Justyna Bobrowska, Andrzej Kubiak et al. · European Biophysics Journal · 2020 · 65 citations · Full text

Natural Sciences, Biomedical Engineering, Biophysics +17

1–5 of 12